Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Talmadge

Showing results (261-270 of 519) with videos related to

Pageof 52
Sort By:
The American Journal of Pathology|September 1, 1987
Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitorsJ E Talmadge, O Bowersox, H Tribble, et al.
International Immunopharmacology|December 21, 2006
CCL21-induced immune cell infiltrationAbdelkader E Ashour, Heth R Turnquist, Rakesh K Singh, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|June 8, 2004
Flt3 ligand bioactivity and pharmacology in neoplasiaA J Reber, A E Ashour, S N Robinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2N S Magnuson, L E Perryman, C R Wyatt, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Antitumor response to recombinant murine interferon gamma correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophagesP L Black, H Phillips, H R Tribble, et al.
Stem Cells (Dayton, Ohio)|July 2, 2003
Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftmentSimon N Robinson, Vladimir M Pisarev, Jennifer M Chavez, et al.
Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combinationS Robinson, R L Mosley, P Parajuli, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 1, 1997
Modulation of MHC isoforms in functionally overloaded and exercised rat plantaris fibersR R Roy, R J Talmadge, K Fox, et al.
Cancer Research|March 1, 1985
Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcelluloseJ E Talmadge, J Adams, H Phillips, et al.
Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Growth factor mobilization and modulation of progenitor cell adhesion to stromal cells: role of VLA-4B Dave, T Watanabe, R K Singh, et al.
Pageof 52

Showing results (261-270 of 519) with videos related to

Sort By:
Pageof 52
The American Journal of Pathology|September 1, 1987
Toxicity of tumor necrosis factor is synergistic with gamma-interferon and can be reduced with cyclooxygenase inhibitorsJ E Talmadge, O Bowersox, H Tribble, et al.
International Immunopharmacology|December 21, 2006
CCL21-induced immune cell infiltrationAbdelkader E Ashour, Heth R Turnquist, Rakesh K Singh, et al.
Current Drug Targets. Immune, Endocrine and Metabolic Disorders|June 8, 2004
Flt3 ligand bioactivity and pharmacology in neoplasiaA J Reber, A E Ashour, S N Robinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Large granular lymphocytes from SCID horses develop potent cytotoxic activity after treatment with human recombinant interleukin 2N S Magnuson, L E Perryman, C R Wyatt, et al.
Cancer Immunology, Immunotherapy : CII|October 1, 1993
Antitumor response to recombinant murine interferon gamma correlates with enhanced immune function of organ-associated, but not recirculating cytolytic T lymphocytes and macrophagesP L Black, H Phillips, H R Tribble, et al.
Stem Cells (Dayton, Ohio)|July 2, 2003
Use of matrix metalloproteinase (MMP)-9 knockout mice demonstrates that MMP-9 activity is not absolutely required for G-CSF or Flt-3 ligand-induced hematopoietic progenitor cell mobilization or engraftmentSimon N Robinson, Vladimir M Pisarev, Jennifer M Chavez, et al.
Journal of Hematotherapy & Stem Cell Research|November 25, 2000
Comparison of the hematopoietic activity of flt-3 ligand and granulocyte-macrophage colony-stimulating factor acting alone or in combinationS Robinson, R L Mosley, P Parajuli, et al.
Journal of Applied Physiology (Bethesda, Md. : 1985)|July 1, 1997
Modulation of MHC isoforms in functionally overloaded and exercised rat plantaris fibersR R Roy, R J Talmadge, K Fox, et al.
Cancer Research|March 1, 1985
Immunotherapeutic potential in murine tumor models of polyinosinic-polycytidylic acid and poly-L-lysine solubilized by carboxymethylcelluloseJ E Talmadge, J Adams, H Phillips, et al.
Journal of Hematotherapy & Stem Cell Research|September 12, 2000
Growth factor mobilization and modulation of progenitor cell adhesion to stromal cells: role of VLA-4B Dave, T Watanabe, R K Singh, et al.
Pageof 52